Cargando…

Editorial: Complement and COVID-19 Disease

Detalles Bibliográficos
Autores principales:	Prohászka, Zoltán, Merle, Nicolas S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284945/ https://www.ncbi.nlm.nih.gov/pubmed/35844521 http://dx.doi.org/10.3389/fimmu.2022.960809

Ejemplares similares

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R
por: Cserhalmi, Marcell, et al.
Publicado: (2017)

Editorial: Expert opinions and perspectives in complement: 2022
por: Okrój, Marcin, et al.
Publicado: (2023)

Expanding Horizons in Complement Analysis and Quality Control
por: Frazer-Abel, Ashley, et al.
Publicado: (2021)

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
por: Hurler, Lisa, et al.
Publicado: (2023)

Editorial: The Role of Complement in Health and Disease
por: Cedzyński, Maciej, et al.
Publicado: (2019)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Editorial: Updates on the complement system in kidney diseases
por: Bulla, Roberta, et al.
Publicado: (2023)

Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus
por: Barkai, László József, et al.
Publicado: (2019)

Editorial: The complement system in autoimmunity
por: Wu, Eveline Y., et al.
Publicado: (2022)

Editorial: The Role of Complement in Tumors
por: Rolfe, Barbara E., et al.
Publicado: (2020)

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
por: Gómez Delgado, Irene, et al.
Publicado: (2021)

Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
por: Uzonyi, Barbara, et al.
Publicado: (2021)

Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation
por: Papp, Alexandra, et al.
Publicado: (2022)

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
por: Sinkovits, György, et al.
Publicado: (2021)

Complement System Part II: Role in Immunity
por: Merle, Nicolas S., et al.
Publicado: (2015)

Editorial: The Role of Complement in Microbial Infections
por: Stoiber, Heribert, et al.
Publicado: (2021)

Complement System Part I – Molecular Mechanisms of Activation and Regulation
por: Merle, Nicolas S., et al.
Publicado: (2015)

Editorial: New insights into the role of complement system in liver diseases
por: Guo, Zhenya, et al.
Publicado: (2023)

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
por: Trojnar, Eszter, et al.
Publicado: (2019)

Editorial: Function and Dysfunction of Complement Factor H
por: Józsi, Mihály, et al.
Publicado: (2022)

Editorial: Complement in the Development and Regeneration of the Nervous System
por: Brennan, Faith H., et al.
Publicado: (2021)

Editorial: Interactions of Pentraxins and Complement in Infection, Inflammation, and Cancer
por: Ma, Ying Jie, et al.
Publicado: (2022)

Editorial: Antimicrobial Peptides and Complement – Maximising the Inflammatory Response
por: Stover, Cordula M.
Publicado: (2015)

A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
por: Pollack, Shirley, et al.
Publicado: (2021)

COVID-19, Pre-Eclampsia, and Complement System
por: Agostinis, Chiara, et al.
Publicado: (2021)

Complement Activation in Kidneys of Patients With COVID-19
por: Pfister, Frederick, et al.
Publicado: (2021)

Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
por: Aigner, Christof, et al.
Publicado: (2023)

Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option
por: Stahel, Philip F., et al.
Publicado: (2020)

Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

COVID, complement, and the brain
por: Vlaicu, Sonia I., et al.
Publicado: (2023)

Atypical HUS and Crohn’s disease—interference of intestinal disease activity with complement-blocking treatment
por: Horváth, Orsolya, et al.
Publicado: (2021)

Complement Factor I Variants in Complement-Mediated Renal Diseases
por: Zhang, Yuzhou, et al.
Publicado: (2022)

Editorial: State-of-the-Art Research on C1q and the Classical Complement Pathway
por: Kishore, Uday, et al.
Publicado: (2016)

Editorial: Therapeutic Modulation of the Complement System: Clinical Indications and Emerging Drug Leads
por: Mastellos, Dimitrios C., et al.
Publicado: (2020)

Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
por: Hurler, Lisa, et al.
Publicado: (2022)

Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19
por: Peerschke, Ellinor I., et al.
Publicado: (2021)

A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein
por: Yatime, Laure, et al.
Publicado: (2018)

Editorial: Complement: Latest developments regarding structure, mechanism, and connections to other proteolytic pathways
por: Dobó, József, et al.
Publicado: (2023)

Complement Therapeutics in Autoimmune Disease
por: Thurman, Joshua M., et al.
Publicado: (2019)

Levels of soluble complement regulators predict severity of COVID-19 symptoms
por: Tierney, Anna L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v465o84d1rihelc9j66dlfoigg